Terence Howard Rabbitts

Title: Terence Howard Rabbitts: Innovator in Chimeric Antibody Production

Introduction

Terence Howard Rabbitts is a notable inventor based in Hildersham, Great Britain. He has made significant contributions to the field of biotechnology, particularly in the production of chimeric antibodies. His innovative work has implications for therapeutic applications in medicine.

Latest Patents

Rabbitts holds a patent for the "Production of chimeric antibodies." This patent describes a process that involves preparing a replicable expression vector with a suitable promoter linked to a DNA sequence. This sequence encodes at least the variable region of an immunoglobulin molecule and part of a second protein. The process includes transforming an immortalized mammalian cell line with the prepared vectors and culturing the transformed cell line to produce the chimeric antibody. The patent also covers the chimeric antibodies produced by this process, as well as the plasmids and transformed cell lines used.

Career Highlights

Throughout his career, Terence Howard Rabbitts has worked with prominent organizations such as Celltech R&D Limited and the Medical Research Council. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Rabbitts has collaborated with esteemed colleagues, including Michael S. Neuberger and Tomoyuki Tanaka. These partnerships have fostered innovation and have been instrumental in his research endeavors.

Conclusion

Terence Howard Rabbitts is a distinguished inventor whose work in chimeric antibody production has made a significant impact in biotechnology. His contributions continue to influence the field and pave the way for future advancements in medical therapies.